Carazolol
Functional Class: Beta-adrenoreceptor blocking agent
Search JECFA
Click the above link to access the relevant JECFA residue monograph(s)
Search WHO
Click the above link to access the relevant WHO evaluation
Maximum residue limits for Carazolol
Species
Tissue
MRL
Year of Adoption
Note
Muscle
5 µg/kg
2003
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Species
Tissue
Muscle
MRL
5 µg/kg
Year of Adoption
2003
Note
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Fat/Skin
5 µg/kg
2003
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.
Species
Tissue
Fat/Skin
MRL
5 µg/kg
Year of Adoption
2003
Note
The concentration at the injection site two hours after treatment may result in an intake that exceeds the acute RfD and therefore, an appropriate withdrawal period should be applied.